Laurus Labs acquires equity shares in KRKA

17 Mar 2025 Evaluate

Laurus Labs has invested Rs 83.30 crore and acquired 83,300,000 equity shares of KRKA Pharma (KRKA) (a joint venture of the Company) a at face value of Rs 10 each by way of rights issue.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C.

Laurus Labs Share Price

1025.50 -20.40 (-1.95%)
06-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.95
Dr. Reddys Lab 1303.90
Cipla 1321.75
Zydus Lifesciences 912.95
Lupin 2344.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×